John P. Sharp - Nov 19, 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Chief Financial Officer
Signature
/s/ John P. Sharp
Stock symbol
PHASQ
Transactions as of
Nov 19, 2021
Transactions value $
$4,054
Form type
4
Date filed
11/23/2021, 05:53 PM
Previous filing
Nov 3, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $4.05K +2.02K +3.49% $2.01* 59.7K Nov 19, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).